AdrienStarck

Associate

Paris + 33.1.56.59.46.20

Adrien Starck's practice focuses on corporate law. He advises international and French companies on a wide range of domestic and cross-border corporate and commercial matters, including M&A, joint ventures, corporate restructurings, and corporate governance.

Experience

  • Sanofi announces carve-out creating EUROAPI and spin-off of approximately 58% of shares to its shareholdersJones Day advised Sanofi in the carve out creating EUROAPI (a leading European company dedicated to the development, production and marketing of active pharmaceutical ingredients) and the listing of this entity on Euronext Paris and the placement of 12% to the French State (through French Tech Souveraineté) for a price of up to €150 million.
  • Kalray acquires Arcapix Holdings Ltd.Jones Day advised Kalray in the acquisition of Arcapix Holdings Ltd, a UK headquartered company that offers high-performance storage and data management solutions for intensive and critical data.
  • Deezer merges with and into I2PO S.A.Jones Day is advising Deezer S.A. in the context of the proposed SPAC transaction whereby Deezer S.A. would be merged with and into I2PO S.A., a French SPAC listed on the professional segment of the regulated market of Euronext Paris and the related PIPE financing.
  • Sanofi sells 10 established products to CheplapharmJones Day advised Sanofi in the sale of a portfolio of pharmaceutical products to Cheplapharm Arzneimittel GmbH, a German privately-owned company headquartered in Greifswald, Germany.
  • Sanofi divests 16 brands to STADAJones Day advised Sanofi in the sale of 16 Consumer Healthcare products commercialized in Europe to STADA Arzneimittel AG.
  • Sanofi sells portfolio of established dental care brands to SeptodontJones Day advised Sanofi in the sale of an integrated portfolio of dental care brands and related medical devices to Septodont, a French privately-owned company headquartered near Paris.
  • Sanofi sells anti-inflammatory drugs to Fidia FarmaceuticiJones Day advised Sanofi in the sale of a portfolio of pharmaceutical products to Fidia Farmaceutici.
  • SUEZ sells its SUEZ Recycling & Recovery operations to PreZeroJones Day advised the French listed company SUEZ SA in its largest sale of SUEZ Recycling & Recovery operations - excluding plastic recycling and hazardous waste treatment activities - in four continental Europe countries: the Netherlands, Luxembourg, Germany, and Poland to PreZero, the environmental division of Schwarz Group.
  • Reno De Medici sells 100% interest in R.D.M. La Rochette S.A.S.Jones Day advised Reno De Medici SpA in the sale of its 100% interest in R.D.M. La Rochette S.A.S. to La Rochette Holding S.A.S., 100% owned by Mutares SE & Co. KgaA.
  • Solvay sold Process Materials business to Composites OneJones Day advised Solvay S.A., a publicly listed chemical company based in Brussels, Belgium, in the sale of its Process Materials business, to Composites One, the leading North American supplier of composites materials and value added services.
  • Catawiki raises €150 million investment led by PermiraJones Day advised Catawiki B.V., Europe's leading curated online marketplace for special objects, on a €150 million investment, led by Permira through its Growth Opportunities Fund.
  • Sanofi sold Effortil (Etilefrin) pharmaceuticals products to SERB SAJones Day advised Sanofi in the sale of the Effortil (Etilefrin) pharmaceuticals products to SERB SA.
  • TotalEnergies reorganizes and refinances two portfolios of solar assets in New Caledonia, France and sells 50% of two portfolios to institutional investorJones Day represented TotalEnergies Renewables France (f.k.a. Total Quadran), as sponsor, in connection with the corporate reorganization and refinancing of two portfolios of solar assets in New Caledonia, France; and legal counsel to Total Quadran on the sale of 50% of the two portfolios to an institutional investor.
  • Sanofi sold "Biopark by Sanofi" to Evotec SEJones Day advised Sanofi in the sale of "Biopark by Sanofi" to Evotec SE.
  • Sanofi sold Lepticur to Laboratoires DelbertJones Day advised Sanofi in the sale of Lepticur to Laboratoires Delbert.
  • Sanofi sold two product portfolios to CHEPLAPHARMJones Day advised Sanofi in the sale of a portfolio of pharmaceuticals products to CHEPLAPHARM Arzneimittel GmbH.
  • Société Générale sells Societe Generale Serbia and Sogelease Serbia to OTP BankJones Day advised Société Générale in the sale of 100% of the shares in its subsidiary Societe Generale Serbia (SGS) and Sogelease Serbia to OTP Bank Nyrt., including the indirect sale of 100% of the shares in SG Leasing (SGS' wholly owned subsidiary dedicated to leasing activities).
  • AURELIUS sells Solidus Solutions for €330 million (US$375.6 million)Jones Day advised AURELIUS Equity Opportunities SE & Co. KGaA on the full shop auction sale of the Solidus Solutions group to funds advised by Centerbridge Partners, L.P.
  • Société Générale sells its majority stake in Mobiasbanca Societe Generale (Moldova) to OTP BankJones Day advised Société Générale in the sale of its majority stake in Mobiasbanca Societe Generale (Moldova) to OTP Bank Nyrt, the leading Hungarian bank.
  • Société Générale sells Societe Generale Montenegro to OTP BankJones Day advised Société Générale in the sale of Societe Generale Montenegro to OTP Bank.